Common Contracts
160 similar Underwriting Agreement contracts by Ra Pharmaceuticals, Inc., Achaogen Inc, Intellia Therapeutics, Inc., others
THE MOSAIC COMPANY $400,000,000 5.375% Senior Notes Due 2028 UNDERWRITING AGREEMENTUnderwriting Agreement • December 7th, 2023 • Mosaic Co • Agricultural chemicals • New York
37,500,000 Common Shares KOSMOS ENERGY LTD. UNDERWRITING AGREEMENTUnderwriting Agreement • October 19th, 2021 • Kosmos Energy Ltd. • Crude petroleum & natural gas • New York
SATSUMA PHARMACEUTICALS, INC. Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • September 3rd, 2019 • Satsuma Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
8,387,097 Shares RA PHARMACEUTICALS, INC. Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • December 14th, 2018 • Ra Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
] Shares Entasis Therapeutics Holdings Inc. COMMON STOCK, PAR VALUE $0.001 PER SHARE UNDERWRITING AGREEMENTUnderwriting Agreement • September 18th, 2018 • Entasis Therapeutics Holdings Inc. • Pharmaceutical preparations • New York
This press release is not an offer for sale of the securities in the United States or in any other jurisdiction where such offer is prohibited, and such securities may not be offered or sold in the United States absent registration or an exemption from registration under the United States Securities Act of 1933, as amended.
TSAKOS ENERGY NAVIGATION LIMITED 5,400,000 Shares Series F Fixed-to-Floating Rate Cumulative Redeemable Perpetual Preferred Shares $1.00 Par Value Per Share (Liquidation Preference $25.00 per share) UNDERWRITING AGREEMENTUnderwriting Agreement • June 28th, 2018 • Tsakos Energy Navigation LTD • Deep sea foreign transportation of freight • New York
7,300,000 Shares Xencor, Inc. COMMON STOCK, PAR VALUE $0.01 PER SHARE UNDERWRITING AGREEMENT March 20, 2018Underwriting Agreement • March 21st, 2018 • Xencor Inc • Pharmaceutical preparations • New York
Introductory. Xencor, Inc., a Delaware corporation (the “Company”), agrees with the several Underwriters named in Schedule A hereto (the “Underwriters”), for whom Leerink Partners LLC (“Leerink”) and Piper Jaffray & Co. are acting as representatives (the “Representatives”) to issue and sell to the several Underwriters 7,300,000 shares (the “Firm Securities”) of its common stock, par value $0.01 per share (the “Securities”) and also agrees to issue and sell to the Underwriters, at the option of the Underwriters, an aggregate of not more than 1,095,000 additional shares (the “Optional Securities”) of its Securities as set forth below. The Firm Securities and the Optional Securities are herein collectively called the “Offered Securities.”
7,058,824 Shares Common Stock Corvus Pharmaceuticals, Inc. UNDERWRITING AGREEMENTUnderwriting Agreement • March 21st, 2018 • Corvus Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
8,400,000 Shares RA PHARMACEUTICALS, INC. Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • February 16th, 2018 • Ra Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Oceaneering International, Inc. UNDERWRITING AGREEMENTUnderwriting Agreement • February 6th, 2018 • Oceaneering International Inc • Oil & gas field services, nec • New York
FTS INTERNATIONAL, INC. Shares of Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • January 23rd, 2018 • FTS International, Inc. • Oil & gas field services, nec • New York
●] Shares PlayAGS, Inc. Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • January 16th, 2018 • PlayAGS, Inc. • Miscellaneous manufacturing industries • New York
] Shares CURO Group Holdings Corp. Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • November 28th, 2017 • CURO Group Holdings Corp. • Finance services • New York
SRC Energy Inc. 35,000,000 Shares of Common Stock, par value $0.001 per share UNDERWRITING AGREEMENTUnderwriting Agreement • November 13th, 2017 • SRC Energy Inc. • Crude petroleum & natural gas • New York
6,250,000 Shares INTELLIA THERAPEUTICS, INC. Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • November 3rd, 2017 • Intellia Therapeutics, Inc. • In vitro & in vivo diagnostic substances • New York
UNDERWRITING AGREEMENTUnderwriting Agreement • October 23rd, 2017 • Earthstone Energy Inc • Crude petroleum & natural gas • New York
•] SHARES ALLENA PHARMACEUTICALS, INC. COMMON STOCK, PAR VALUE $0.001 PER SHARE UNDERWRITING AGREEMENTUnderwriting Agreement • October 6th, 2017 • Allena Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • New York
4,400,000 Ordinary Shares Par Value NIS 0.01 MEDIWOUND LTD. UNDERWRITING AGREEMENTUnderwriting Agreement • September 19th, 2017 • MediWound Ltd. • Medicinal chemicals & botanical products • New York
5,000,000 Shares RANGER ENERGY SERVICES, INC. Class A Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • August 1st, 2017 • Ranger Energy Services, Inc. • Oil & gas field services, nec • New York
UNDERWRITING AGREEMENTUnderwriting Agreement • May 31st, 2017 • Achaogen Inc • Pharmaceutical preparations • New York
•] Shares SOLARIS OILFIELD INFRASTRUCTURE, INC. Class A common stock FORM OF UNDERWRITING AGREEMENTUnderwriting Agreement • April 18th, 2017 • Solaris Oilfield Infrastructure, Inc. • Oil & gas field machinery & equipment • New York
TSAKOS ENERGY NAVIGATION LIMITED 4,000,000 Shares Series E Fixed-to-Floating Rate Cumulative Redeemable Perpetual Preferred Shares $1.00 Par Value Per Share (Liquidation Preference $25.00 per share) UNDERWRITING AGREEMENTUnderwriting Agreement • April 5th, 2017 • Tsakos Energy Navigation LTD • Deep sea foreign transportation of freight • New York
13,500,000 Shares CLOUD PEAK ENERGY INC. Common Stock, $0.01 par value UNDERWRITING AGREEMENTUnderwriting Agreement • February 28th, 2017 • Cloud Peak Energy Inc. • Bituminous coal & lignite surface mining • New York
violation of any Applicable Laws applicable to the Company or any judgment, order or regulation known to us of any court or governmental or regulatory authority of the United States, New York State or Delaware applying or interpreting the Delaware General Corporation Law, except, in the case of clauses (A) and (C) above, for any such conflict, breach, violation, default, lien, charge or encumbrance that would not, individually or in the aggregate, have a Material Adverse Effect. With respect to clause (C) above, we express no opinion as to the application of any state securities or Blue Sky laws or federal or state antifraud laws, rules or regulations.
29,000,000 Shares LAUREATE EDUCATION, INC. Class A Common Stock Form of UNDERWRITING AGREEMENTUnderwriting Agreement • January 18th, 2017 • Laureate Education, Inc. • Services-educational services • New York
ATWOOD OCEANICS, INC. 13,500,000 Shares Common Stock (par value $1.00 per share) UNDERWRITING AGREEMENTUnderwriting Agreement • January 13th, 2017 • Atwood Oceanics Inc • Drilling oil & gas wells • New York
29,000,000 Shares GULFPORT ENERGY CORPORATION Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • December 21st, 2016 • Gulfport Energy Corp • Crude petroleum & natural gas • New York
UNDERWRITING AGREEMENTUnderwriting Agreement • December 19th, 2016 • Achaogen Inc • Pharmaceutical preparations • New York
RA PHARMACEUTICALS, INC. Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • October 17th, 2016 • Ra Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
l ] Shares MyoKardia, Inc. Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • September 26th, 2016 • MyoKardia Inc • Pharmaceutical preparations • New York
UNDERWRITING AGREEMENTUnderwriting Agreement • September 16th, 2016 • Callidus Software Inc • Services-computer programming services • New York
3,750,000 Shares B&G Foods, Inc. Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • August 10th, 2016 • B&G Foods, Inc. • Food and kindred products • New York
UNDERWRITING AGREEMENTUnderwriting Agreement • May 16th, 2016 • GMS Inc. • Wholesale-lumber & other construction materials • New York
Shares INTELLIA THERAPEUTICS, INC. Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • April 27th, 2016 • Intellia Therapeutics, Inc. • In vitro & in vivo diagnostic substances • New York
PERFORMANCE HEALTH HOLDINGS CORP. Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • April 22nd, 2016 • Performance Health Holdings Corp. • Pharmaceutical preparations • New York
PERFORMANCE HEALTH HOLDINGS CORP. Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • March 18th, 2016 • Performance Health Holdings Corp. • Pharmaceutical preparations • New York
